1009 related articles for article (PubMed ID: 28612290)
1. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME
Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290
[TBL] [Abstract][Full Text] [Related]
2. Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden.
Haure-Mirande JV; Wang M; Audrain M; Fanutza T; Kim SH; Heja S; Readhead B; Dudley JT; Blitzer RD; Schadt EE; Zhang B; Gandy S; Ehrlich ME
Mol Psychiatry; 2019 Mar; 24(3):431-446. PubMed ID: 30283032
[TBL] [Abstract][Full Text] [Related]
3. Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer's-related mice.
Audrain M; Haure-Mirande JV; Mleczko J; Wang M; Griffin JK; St George-Hyslop PH; Fraser P; Zhang B; Gandy S; Ehrlich ME
Alzheimers Dement; 2021 Feb; 17(2):149-163. PubMed ID: 33314529
[TBL] [Abstract][Full Text] [Related]
4. Microglial TYROBP/DAP12 in Alzheimer's disease: Transduction of physiological and pathological signals across TREM2.
Haure-Mirande JV; Audrain M; Ehrlich ME; Gandy S
Mol Neurodegener; 2022 Aug; 17(1):55. PubMed ID: 36002854
[TBL] [Abstract][Full Text] [Related]
5. Effects of TYROBP Deficiency on Neuroinflammation of a Alzheimer's Disease Mouse Model Carrying a
Li R; Lv ZY; Li YX; Li W; Hao YL
Chin Med Sci J; 2022 Dec; 37(4):320-330. PubMed ID: 36171177
[TBL] [Abstract][Full Text] [Related]
6. Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau.
Audrain M; Haure-Mirande JV; Wang M; Kim SH; Fanutza T; Chakrabarty P; Fraser P; St George-Hyslop PH; Golde TE; Blitzer RD; Schadt EE; Zhang B; Ehrlich ME; Gandy S
Mol Psychiatry; 2019 Sep; 24(9):1383-1397. PubMed ID: 30283031
[TBL] [Abstract][Full Text] [Related]
7. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models.
Sekiya M; Wang M; Fujisaki N; Sakakibara Y; Quan X; Ehrlich ME; De Jager PL; Bennett DA; Schadt EE; Gandy S; Ando K; Zhang B; Iijima KM
Genome Med; 2018 Mar; 10(1):26. PubMed ID: 29598827
[TBL] [Abstract][Full Text] [Related]
8. Bilberry anthocyanins improve neuroinflammation and cognitive dysfunction in APP/PSEN1 mice via the CD33/TREM2/TYROBP signaling pathway in microglia.
Li J; Zhao R; Jiang Y; Xu Y; Zhao H; Lyu X; Wu T
Food Funct; 2020 Feb; 11(2):1572-1584. PubMed ID: 32003387
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.
Takahashi H; Klein ZA; Bhagat SM; Kaufman AC; Kostylev MA; Ikezu T; Strittmatter SM;
Acta Neuropathol; 2017 May; 133(5):785-807. PubMed ID: 28070672
[TBL] [Abstract][Full Text] [Related]
10. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
[TBL] [Abstract][Full Text] [Related]
12. Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology.
Readhead B; Haure-Mirande JV; Zhang B; Haroutunian V; Gandy S; Schadt EE; Dudley JT; Ehrlich ME
Mol Psychiatry; 2016 Aug; 21(8):1099-111. PubMed ID: 26552589
[TBL] [Abstract][Full Text] [Related]
13. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.
Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S
Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of TREM2 Ameliorates Neuroinflammatory Responses and Improves Cognitive Deficits Triggered by Surgical Trauma in Appswe/PS1dE9 Mice.
Jiang Y; Li Z; Ma H; Cao X; Liu F; Tian A; Sun X; Li X; Wang J
Cell Physiol Biochem; 2018; 46(4):1398-1411. PubMed ID: 29689568
[TBL] [Abstract][Full Text] [Related]
15. TYROBP in Alzheimer's disease.
Ma J; Jiang T; Tan L; Yu JT
Mol Neurobiol; 2015 Apr; 51(2):820-6. PubMed ID: 25052481
[TBL] [Abstract][Full Text] [Related]
16. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
[TBL] [Abstract][Full Text] [Related]
17. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
[No Abstract] [Full Text] [Related]
18. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of TREM2/DAP12 complex affecting β-amyloid plaque deposition in Alzheimer's disease modeled mice through mediating inflammatory response.
Cui X; Qiao J; Liu S; Wu M; Gu W
Brain Res Bull; 2021 Jan; 166():21-28. PubMed ID: 33053435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
